Condensed Interim Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from Operating Activities
Net Loss	$ (7,533,063)	$ (4,538,527)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities
Stock based compensation	384,809	400,450
Bad debt (recovery) expense	(135,467)	55,226
Change in fair market value of warrant liability	(918)	(11,717)
Change in fair market value of contingent consideration	433,999	240,000
Gain on settlement of contingent consideration	0	(1,700,000)
Loss on impairment of goodwill and intangible assets	0	1,138,203
Amortization of right-of-use asset	236,275	462,832
Depreciation and amortization	1,418,127	978,495
Amortization of debt discount	399,129	53,646
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(1,670,165)	(402,965)
Cost and estimated earnings excess of billings	(595,560)	(262,420)
Inventory	1,311,288	(2,855,073)
Vendor deposits	(698,165)	494,888
Prepaid expenses and other current assets	(194,044)	(62,600)
Accounts payable and accrued expenses	2,088,635	768,872
Billings in excess of costs and earnings on uncompleted contracts	0	(616,475)
Deferred revenue	(1,622,314)	687,494
Due to landlord	(186,344)	(93,172)
Operating lease payments	(213,125)	(449,388)
Net Cash Used in Operating Activities	(6,576,903)	(5,712,231)
Cash Flows From Investing Activities
Cash paid for patent costs	(51,077)	(682)
Purchase of machinery and equipment	(75,959)	(26,043)
Acquisitions, net of cash acquired (Note 2)	(4,115,709)	(10)
Payments on notes payable	(166,262)	0
Net Cash Used in Investing Activities	(4,409,007)	(26,735)
Cash Flows From Financing Activities
Payments on financing leases	(20,022)	(3,493)
Shares repurchased	0	(149,686)
Dividends to preferred shareholders	(769,481)	(724,500)
Payments on note payable	(16,438,782)	0
Proceeds from equity raises, net	6,630,799	1,092,000
Proceeds from note payable, net	22,182,455	0
Net Cash Provided by Financing Activities	11,584,969	214,321
Net Increase (Decrease) in Cash and equivalents	599,059	(5,524,645)
Cash and cash equivalents at January 1,	2,734,485	8,768,156
Cash and cash equivalents at June 30,	3,333,544	3,243,511
Cash paid during the year for:
Interest	308,955	4,102
Supplemental Non-Cash Disclosures of Investing and Financing Activities
Conversion of debt into common stock	217,500	0
Recognition of right of use asset and corresponding lease liability	$ 563,315	$ 1,380,658